Recent advances in understanding the roles of vascular endothelial cells in allergic inflammation

Tetsuo Shoda, Kyoko Futamura, Kanami Orihara, Maiko Emi-Sugie, Hirohisa Saito, Kenji Matsumoto, Akio Matsuda

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Allergic disorders commonly involve both chronic tissue inflammation and remodeling caused by immunological reactions to various antigens on tissue surfaces. Due to their anatomical location, vascular endothelial cells are the final responders to interact with various exogenous factors that come into contact with the epithelial surface, such as pathogen-associated molecular patterns (PAMPs) and antigens. Recent studies have shed light on the important roles of endothelial cells in the development and exacerbation of allergic disorders. For instance, endothelial cells have the greatest potential to produce several key molecules that are deeply involved in allergic inflammation, such as periostin and thymus and activation-regulated chemokine (TARC/CCL17). Additionally, endothelial cells were recently shown to be important functional targets for IL-33 - an essential regulator of allergic inflammation. Notably, almost all endothelial cell responses and functions involved in allergic inflammation are not suppressed by corticosteroids. These corticosteroid-refractory endothelial cell responses and functions include TNF-α-associated angiogenesis, leukocyte adhesion, IL-33-mediated responses and periostin and TARC production. Therefore, these unique responses and functions of endothelial cells may be critically involved in the pathogenesis of various allergic disorders, especially their refractory processes. Here, we review recent studies, including ours, which have elucidated previously unknown pathophysiological roles of vascular endothelial cells in allergic inflammation and discuss the possibility of endothelium-targeted therapy for allergic disorders.

Original languageEnglish
Pages (from-to)21-29
Number of pages9
JournalAllergology International
Volume65
Issue number1
DOIs
Publication statusPublished - 2016 Jan 1
Externally publishedYes

Fingerprint

Endothelial Cells
Inflammation
Chemokine CCL17
Adrenal Cortex Hormones
Antigens
Endothelium
Leukocytes

Keywords

  • Allergy
  • Angiogenesis
  • Corticosteroid
  • Endothelial cells
  • Inflammation

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Recent advances in understanding the roles of vascular endothelial cells in allergic inflammation. / Shoda, Tetsuo; Futamura, Kyoko; Orihara, Kanami; Emi-Sugie, Maiko; Saito, Hirohisa; Matsumoto, Kenji; Matsuda, Akio.

In: Allergology International, Vol. 65, No. 1, 01.01.2016, p. 21-29.

Research output: Contribution to journalReview article

Shoda, Tetsuo ; Futamura, Kyoko ; Orihara, Kanami ; Emi-Sugie, Maiko ; Saito, Hirohisa ; Matsumoto, Kenji ; Matsuda, Akio. / Recent advances in understanding the roles of vascular endothelial cells in allergic inflammation. In: Allergology International. 2016 ; Vol. 65, No. 1. pp. 21-29.
@article{d0fcaf048b4e4622b3300bdf87ef7ae8,
title = "Recent advances in understanding the roles of vascular endothelial cells in allergic inflammation",
abstract = "Allergic disorders commonly involve both chronic tissue inflammation and remodeling caused by immunological reactions to various antigens on tissue surfaces. Due to their anatomical location, vascular endothelial cells are the final responders to interact with various exogenous factors that come into contact with the epithelial surface, such as pathogen-associated molecular patterns (PAMPs) and antigens. Recent studies have shed light on the important roles of endothelial cells in the development and exacerbation of allergic disorders. For instance, endothelial cells have the greatest potential to produce several key molecules that are deeply involved in allergic inflammation, such as periostin and thymus and activation-regulated chemokine (TARC/CCL17). Additionally, endothelial cells were recently shown to be important functional targets for IL-33 - an essential regulator of allergic inflammation. Notably, almost all endothelial cell responses and functions involved in allergic inflammation are not suppressed by corticosteroids. These corticosteroid-refractory endothelial cell responses and functions include TNF-α-associated angiogenesis, leukocyte adhesion, IL-33-mediated responses and periostin and TARC production. Therefore, these unique responses and functions of endothelial cells may be critically involved in the pathogenesis of various allergic disorders, especially their refractory processes. Here, we review recent studies, including ours, which have elucidated previously unknown pathophysiological roles of vascular endothelial cells in allergic inflammation and discuss the possibility of endothelium-targeted therapy for allergic disorders.",
keywords = "Allergy, Angiogenesis, Corticosteroid, Endothelial cells, Inflammation",
author = "Tetsuo Shoda and Kyoko Futamura and Kanami Orihara and Maiko Emi-Sugie and Hirohisa Saito and Kenji Matsumoto and Akio Matsuda",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.alit.2015.08.001",
language = "English",
volume = "65",
pages = "21--29",
journal = "Allergology International",
issn = "1323-8930",
publisher = "Japanese Society of Allergology",
number = "1",

}

TY - JOUR

T1 - Recent advances in understanding the roles of vascular endothelial cells in allergic inflammation

AU - Shoda, Tetsuo

AU - Futamura, Kyoko

AU - Orihara, Kanami

AU - Emi-Sugie, Maiko

AU - Saito, Hirohisa

AU - Matsumoto, Kenji

AU - Matsuda, Akio

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Allergic disorders commonly involve both chronic tissue inflammation and remodeling caused by immunological reactions to various antigens on tissue surfaces. Due to their anatomical location, vascular endothelial cells are the final responders to interact with various exogenous factors that come into contact with the epithelial surface, such as pathogen-associated molecular patterns (PAMPs) and antigens. Recent studies have shed light on the important roles of endothelial cells in the development and exacerbation of allergic disorders. For instance, endothelial cells have the greatest potential to produce several key molecules that are deeply involved in allergic inflammation, such as periostin and thymus and activation-regulated chemokine (TARC/CCL17). Additionally, endothelial cells were recently shown to be important functional targets for IL-33 - an essential regulator of allergic inflammation. Notably, almost all endothelial cell responses and functions involved in allergic inflammation are not suppressed by corticosteroids. These corticosteroid-refractory endothelial cell responses and functions include TNF-α-associated angiogenesis, leukocyte adhesion, IL-33-mediated responses and periostin and TARC production. Therefore, these unique responses and functions of endothelial cells may be critically involved in the pathogenesis of various allergic disorders, especially their refractory processes. Here, we review recent studies, including ours, which have elucidated previously unknown pathophysiological roles of vascular endothelial cells in allergic inflammation and discuss the possibility of endothelium-targeted therapy for allergic disorders.

AB - Allergic disorders commonly involve both chronic tissue inflammation and remodeling caused by immunological reactions to various antigens on tissue surfaces. Due to their anatomical location, vascular endothelial cells are the final responders to interact with various exogenous factors that come into contact with the epithelial surface, such as pathogen-associated molecular patterns (PAMPs) and antigens. Recent studies have shed light on the important roles of endothelial cells in the development and exacerbation of allergic disorders. For instance, endothelial cells have the greatest potential to produce several key molecules that are deeply involved in allergic inflammation, such as periostin and thymus and activation-regulated chemokine (TARC/CCL17). Additionally, endothelial cells were recently shown to be important functional targets for IL-33 - an essential regulator of allergic inflammation. Notably, almost all endothelial cell responses and functions involved in allergic inflammation are not suppressed by corticosteroids. These corticosteroid-refractory endothelial cell responses and functions include TNF-α-associated angiogenesis, leukocyte adhesion, IL-33-mediated responses and periostin and TARC production. Therefore, these unique responses and functions of endothelial cells may be critically involved in the pathogenesis of various allergic disorders, especially their refractory processes. Here, we review recent studies, including ours, which have elucidated previously unknown pathophysiological roles of vascular endothelial cells in allergic inflammation and discuss the possibility of endothelium-targeted therapy for allergic disorders.

KW - Allergy

KW - Angiogenesis

KW - Corticosteroid

KW - Endothelial cells

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=84952874010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952874010&partnerID=8YFLogxK

U2 - 10.1016/j.alit.2015.08.001

DO - 10.1016/j.alit.2015.08.001

M3 - Review article

VL - 65

SP - 21

EP - 29

JO - Allergology International

JF - Allergology International

SN - 1323-8930

IS - 1

ER -